ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 910

$1M Total Retail Price of All Prescriptions

Rank: 20 out of 910

817 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 817 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 817 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,610 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 632 609 1 3
LEVOTHYROXINE SODIUM 470 456 2 1
LISINOPRIL 460 443 3 2
LOSARTAN POTASSIUM 435 428 4 15
ATORVASTATIN CALCIUM 397 387 5 14
METFORMIN HCL 369 336 6 6
OMEPRAZOLE 355 329 7 5
CRESTOR 346 330 8 26
FLUTICASONE PROPIONATE 341 325 9 23
AMLODIPINE BESYLATE 289 281 10 4
CARVEDILOL 276 263 11 36
FENOFIBRATE 209 194 12 55
ZOLPIDEM TARTRATE 205 194 13 17
METOPROLOL SUCCINATE 183 183 14 21
CITALOPRAM HBR 161 145 15 19
HYDROCODONE-ACETAMINOPHEN 152 151 S3 16 8
WARFARIN SODIUM 144 141 17 11
TAMSULOSIN HCL 142 137 18 29
AZITHROMYCIN 141 137 19 41
LOSARTAN-HYDROCHLOROTHIAZIDE 124 120 20 79
METOPROLOL TARTRATE 121 114 21 7
ALLOPURINOL 116 114 22 33
HYDROCHLOROTHIAZIDE 113 113 23 12
SYNTHROID 109 109 24 54
ALENDRONATE SODIUM 108 104 25 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 105 26 44
FINASTERIDE 102 99 27 59
GABAPENTIN 102 94 27 13
TRAMADOL HCL 96 96 29 25
BYSTOLIC 95 95 30 204
GLIMEPIRIDE 95 93 30 56
DIOVAN 89 89 32 34
PANTOPRAZOLE SODIUM 89 79 32 27
CYMBALTA 83 76 34 58
VYTORIN 82 71 35 82
PRAVASTATIN SODIUM 78 78 36 16
TERAZOSIN HCL 78 78 36 61
CIPROFLOXACIN HCL 76 72 38 48
CLOPIDOGREL 75 75 39 35
POTASSIUM CHLORIDE 71 71 40 18
ESCITALOPRAM OXALATE 69 68 41 113
LOVASTATIN 64 63 42 20
FUROSEMIDE 64 64 42 9
PREDNISONE 63 63 44 43
CELEBREX 61 59 45 85
ATENOLOL 59 57 46 10
NEXIUM 59 59 46 93
SPIRIVA 55 55 48 74
LIPITOR 55 55 48 97
RAMIPRIL 55 55 48 154
SPIRONOLACTONE 54 54 51 66
CLONIDINE HCL 54 54 51 51
ESTRADIOL 53 52 R 53 92
CEPHALEXIN 53 53 53 90
HYDRALAZINE HCL 51 51 55 65
LORAZEPAM 51 50 55 151
BENICAR 51 51 55 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.